Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results

Table 2

Treatment characteristics.

Characteristic	Value
Selectivity of 90Y injection: whole liver/lobar/segmental	0/17/1
Median (range) activity (GBq)	2.5 (1.31–7.51)
Median (range) dose to the target volume (Gy)	117.8 (80.1–164.1)
Median (range) dose to the nontumoral liver (Gy)	75.5 (26.5–114.5)
Median (range) dose to the lungs (Gy)	3.8 (0–28.5)
Median (range) dose to the tumour (Gy)	261.1 (114.5–393.9)
Median (range) pulmonary shunt fraction (%)	2.4 (0–43.5)
Median (range) dose of controlled patients (complete response + partial response + stable disease)	284.5 (194.0–393.9)
Median (range) dose of nonresponders patients	181.5 (114.5–248.6)